Koichi Fukunaga Selected Research

Therapeutics

10/2023	Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study.
7/2023	Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung Cancer.
6/2023	Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents.
6/2023	Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma.
1/2023	Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review.
12/2022	Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force.
12/2022	Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer.
11/2022	Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.
1/2022	Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma.
1/2022	Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Fukunaga Research Topics

Disease

39	Asthma (Bronchial Asthma) 01/2024 - 12/2004
29	COVID-19 04/2024 - 08/2020
23	Inflammation (Inflammations) 10/2023 - 12/2004
15	Pneumonia (Pneumonitis) 10/2023 - 08/2009
14	Neoplasms (Cancer) 04/2024 - 01/2018
11	Infections 04/2024 - 02/2013
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 11/2003
8	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2015
8	Rhinosinusitis 04/2023 - 04/2015
7	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2009
7	Acute Lung Injury 09/2017 - 04/2005
4	Nasal Polyps (Nasal Polyp) 01/2023 - 04/2015
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 06/2009
4	Lung Diseases (Lung Disease) 01/2022 - 12/2009
4	Obstructive Sleep Apnea 01/2021 - 07/2016
4	Lung Injury 10/2010 - 08/2008
3	Bacterial Infections (Bacterial Infection) 04/2024 - 12/2022
3	Post-Acute COVID-19 Syndrome 01/2024 - 11/2023
3	Adenocarcinoma of Lung 01/2023 - 01/2020
3	Dyspnea (Shortness of Breath) 11/2022 - 08/2012
3	Emphysema 08/2022 - 08/2012
3	Fibrosis (Cirrhosis) 01/2021 - 06/2009
3	Respiratory Hypersensitivity 06/2014 - 12/2004
3	Sepsis (Septicemia) 04/2014 - 08/2009
2	Heart Failure 04/2024 - 10/2023
2	Liver Diseases (Liver Disease) 04/2024 - 10/2023
2	Thromboembolism 04/2024 - 10/2023
2	Diarrhea 01/2024 - 01/2022
2	Hypertension (High Blood Pressure) 11/2023 - 01/2018
2	Fever (Fevers) 11/2022 - 05/2021
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 11/2022 - 01/2021
2	Atrial Fibrillation 11/2022 - 01/2018
2	Osteoporosis 05/2022 - 08/2012
2	Weight Loss (Weight Reduction) 01/2022 - 10/2021
2	Disease Progression 01/2022 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 10/2020
2	Bronchiectasis 08/2020 - 01/2018
2	Eosinophilia 05/2014 - 01/2008

Drug/Important Bio-Agent (IBA)

14	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 08/2012
10	CytokinesIBA 01/2024 - 05/2014
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2012
9	Oxygen (Dioxygen)IBA 04/2024 - 08/2012
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2010
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2014
5	InterleukinsIBA 10/2023 - 05/2014
5	SteroidsIBA 07/2023 - 07/2021
5	AntibodiesIBA 06/2023 - 01/2018
5	SmokeIBA 08/2022 - 01/2018
4	AllergensIBA 11/2023 - 01/2008
4	Interleukin-13IBA 10/2023 - 04/2015
4	NivolumabIBA 08/2023 - 01/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2023 - 04/2015
3	C-Reactive ProteinIBA 01/2024 - 05/2021
3	Immunoglobulin E (IgE)IBA 01/2024 - 01/2018
3	AntigensIBA 01/2024 - 09/2015
3	Immunoglobulin G (IgG)IBA 11/2023 - 05/2014
3	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2022
3	dupilumabIBA 10/2023 - 11/2022
3	Immune Checkpoint InhibitorsIBA 09/2023 - 07/2023
3	pembrolizumabIBA 08/2023 - 01/2021
3	Neutralizing AntibodiesIBA 12/2022 - 01/2021
3	Interleukin-5 (Interleukin 5)IBA 11/2022 - 03/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 06/2009
3	PeriostinIBA 01/2021 - 04/2015
3	Interleukin-33IBA 01/2017 - 01/2013
3	Methacholine Chloride (Methacholine)FDA Link 05/2014 - 01/2008
3	ProstaglandinsIBA 01/2011 - 04/2006
3	HMGB1 Protein (HMG1)IBA 12/2010 - 08/2009
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008 - 04/2005
2	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 11/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 05/2014
2	baricitinibIBA 07/2023 - 12/2022
2	Antiviral Agents (Antivirals)IBA 06/2023 - 07/2015
2	Anti-Infective Agents (Microbicides)IBA 04/2023 - 07/2015
2	Thymic Stromal LymphopoietinIBA 01/2023 - 01/2013
2	LigandsIBA 01/2023 - 08/2008
2	Muscarinic AntagonistsIBA 01/2023 - 01/2015
2	remdesivirIBA 12/2022 - 01/2021
2	AnticoagulantsIBA 11/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 11/2022 - 08/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2022
2	Ferritins (Ferritin)IBA 12/2021 - 05/2021
2	Indicators and Reagents (Reagents)IBA 05/2021 - 12/2009
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Interleukin-27 (Interleukin 27)IBA 01/2021 - 01/2016
2	LipidsIBA 01/2021 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2006
2	prostaglandin D2 receptorIBA 01/2019 - 01/2011
2	Interleukin-23 (Interleukin 23)IBA 09/2015 - 05/2014
2	LipopolysaccharidesIBA 05/2015 - 08/2008
2	EndotoxinsIBA 12/2010 - 08/2008
2	AcidsIBA 01/2010 - 04/2006

Therapy/Procedure

23	Therapeutics 10/2023 - 04/2005
6	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2021
6	Drug Therapy (Chemotherapy) 09/2023 - 12/2009
3	Continuous Positive Airway Pressure 06/2020 - 07/2016
2	Radiotherapy 01/2021 - 06/2009
2	Pneumonectomy (Lung Volume Reduction) 08/2020 - 06/2009